Related Experiment Video
Updated: Jun 16, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
GABAA Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders
1The Second Norman Bethune of Jilin University, Changchun, Jilin, 130000, People's Republic of China.
None:
Depression is a serious mental disorder that affects individuals across diverse demographic and socioeconomic groups. Its pathophysiology is multifactorial and incompletely understood, and currently available pharmacological treatments remain limited in efficacy and scope. This article examines the involvement of the gamma-aminobutyric acid (GABA)ergic system in the pathogenesis of depression and reviews the pharmacological effects, therapeutic efficacy, and recent research developments related to various GABAA receptor modulators in the treatment of depressive disorders, including benzodiazepines, intravenous anesthetics, and neurosteroids. These agents may exert antidepressant and anxiolytic effects through modulation and restoration of GABAergic neurotransmission. In addition, certain agents, such as etomidate and allopregnanolone, have been reported to enhance synaptic plasticity and attenuate neuroinflammatory processes, thereby contributing to the reduction of depressive symptoms through multiple neurobiological mechanisms.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
G-protein Coupled Receptors
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antidepressant Drugs: Overview